Literature DB >> 10604260

Docetaxel (Taxotere) in hormone-refractory prostate cancer: a new addition to the physicians' toolbag.

N J Vogelzang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10604260

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  2 in total

Review 1.  Docetaxel: a review of its use in non-small cell lung cancer.

Authors:  A M Comer; K L Goa
Journal:  Drugs Aging       Date:  2000-07       Impact factor: 3.923

2.  Natural compound Alternol induces oxidative stress-dependent apoptotic cell death preferentially in prostate cancer cells.

Authors:  Yuzhe Tang; Ruibao Chen; Yan Huang; Guodong Li; Yiling Huang; Jiepeng Chen; Lili Duan; Bao-Ting Zhu; J Brantley Thrasher; Xu Zhang; Benyi Li
Journal:  Mol Cancer Ther       Date:  2014-03-31       Impact factor: 6.261
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.